|
CN1241139A
(zh)
*
|
1996-12-20 |
2000-01-12 |
武田药品工业株式会社 |
生产缓释制剂的方法
|
|
WO2000021559A2
(en)
|
1998-10-09 |
2000-04-20 |
Musc Foundation For Research Development |
Blocking factor b to treat complement-mediated immune disease
|
|
US8329169B2
(en)
|
2003-05-15 |
2012-12-11 |
Genentech, Inc. |
Methods and compositions for the prevention and treatment of sepsis
|
|
CN1289066C
(zh)
*
|
2003-09-18 |
2006-12-13 |
中国人民解放军第二军医大学 |
胰高血糖素样肽－1缓释微球制剂及其用途
|
|
CA2610502A1
(en)
|
2005-03-29 |
2006-10-05 |
Cardax Pharmaceuticals, Inc. |
Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof
|
|
CA2610340C
(en)
|
2005-05-26 |
2016-02-16 |
Vernon Michael Holers |
Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions
|
|
MX2008004094A
(es)
|
2005-09-27 |
2009-02-27 |
Efrat Biopolymers Ltd |
Composiciones de polimero inyectables hidrofobicas, gelificantes.
|
|
EP3299027A1
(en)
|
2005-11-04 |
2018-03-28 |
Genentech, Inc. |
Use of complement pathway inhibitors to treat ocular diseases
|
|
CN101341254A
(zh)
*
|
2005-12-24 |
2009-01-07 |
蒂加斯克乳制品研究中心 |
反-10，顺-12十八碳二烯酸的生产方法
|
|
US20090028832A1
(en)
*
|
2006-08-10 |
2009-01-29 |
Chung Leland F |
Compositions and methods for targeted tumor therapy
|
|
LT3028716T
(lt)
|
2006-10-10 |
2020-12-10 |
Regenesance B.V. |
Komplemento slopinimas nervų regeneracijos pagerinimui
|
|
US7736860B2
(en)
|
2006-11-09 |
2010-06-15 |
Univeristy Of Massachusetts |
Methods of identifying compounds for the treatment of sterile inflammation
|
|
US20100015139A1
(en)
|
2008-07-10 |
2010-01-21 |
Rekha Bansal |
METHOD OF INHIBITING COMPLEMENT ACTIVATION WITH FACTOR Ba SPECIFIC ANTIBODIES AND USE THEREOF
|
|
US20080269318A1
(en)
|
2007-04-30 |
2008-10-30 |
Carmelo Romano |
Treatment of age-related macular degeneration using inhibitors of complement factor d
|
|
BRPI0812767A2
(pt)
|
2007-06-07 |
2014-12-02 |
Genentech Inc |
Anticorpos para c3b e métodos para prevenção e tratamento de distúrbios associados ao complemento
|
|
WO2009014633A1
(en)
|
2007-07-20 |
2009-01-29 |
Trustees Of The University Of Pennsylvania |
Method of treating acute respiratory distress syndrome
|
|
JP5473925B2
(ja)
|
2007-10-27 |
2014-04-16 |
コーデン ファーマ コロラド インコーポレイテッド |
固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
|
|
WO2010025510A1
(en)
|
2008-09-03 |
2010-03-11 |
Xenome Ltd |
Libraries of peptide conjugates and methods for making them
|
|
US20100086596A1
(en)
*
|
2008-10-06 |
2010-04-08 |
Oakwood Laboratories LLC |
Microspheres for releasing an octreotide compound without an initial time lag
|
|
LT2894165T
(lt)
|
2008-11-10 |
2023-03-10 |
Alexion Pharmaceuticals, Inc. |
Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui
|
|
CN102781471B
(zh)
|
2009-10-16 |
2016-10-12 |
奥默罗斯公司 |
通过抑制masp-2依赖性补体活化治疗弥散性血管内凝血的方法
|
|
WO2011106635A1
(en)
|
2010-02-25 |
2011-09-01 |
The Trustees Of The University Of Pennsylvania |
Treatment of sepsis using complement inhibitors
|
|
EP2563359A1
(en)
|
2010-04-30 |
2013-03-06 |
Allergan, Inc. |
Novel treatment for age related macular degeneration and ocular ischemic disease associated with complement activation by targeting 5-lipoxygenase
|
|
TW201241008A
(en)
*
|
2010-10-01 |
2012-10-16 |
Alexion Pharma Inc |
Polypeptides that bind to human complement component C5
|
|
KR101870915B1
(ko)
|
2011-04-08 |
2018-06-25 |
유니버시티 오브 레스터 |
Ｍａｓｐ-2 의존적 보체 활성화와 관련된 질병을 치료하는 방법
|
|
WO2012162215A1
(en)
|
2011-05-20 |
2012-11-29 |
The Trustees Of The University Of Pennsylvania |
Promotion of fracture healing using complement inhibitors
|
|
WO2012174055A1
(en)
|
2011-06-13 |
2012-12-20 |
The Trustees Of The University Of Pennsylvania |
Wound healing using complement inhibitors
|
|
US20130246083A1
(en)
|
2012-03-16 |
2013-09-19 |
Alexion Pharmaceuticals, Inc. |
Methods of distributing complement-inhibiting drugs to patients receiving a complement inhibitor
|
|
US9579360B2
(en)
|
2012-06-20 |
2017-02-28 |
The Trustees Of The University Of Pennsylvania |
Methods of treating or preventing periodontitis and diseases associated with periodontitis
|
|
US20130345257A1
(en)
|
2012-06-26 |
2013-12-26 |
The Regents Of The University Of California |
Composition for lupus nephritis and methods of making and using the same
|
|
WO2014078622A1
(en)
|
2012-11-15 |
2014-05-22 |
The Brigham And Women's Hospital, Inc. |
Method and system for diagnosing and treating preeclampsia
|
|
US20140234275A1
(en)
|
2013-02-15 |
2014-08-21 |
Jason Williams |
Method for treating als via the increased production of factor h
|
|
US20160324798A1
(en)
*
|
2013-12-31 |
2016-11-10 |
Heron Therapeutics, Inc. |
Polymer-based compositions for extended release of proteins
|
|
AU2015274482B2
(en)
*
|
2014-06-12 |
2018-11-08 |
Ucb Holdings, Inc. |
Modulation of complement activity
|
|
WO2016138520A1
(en)
|
2015-02-27 |
2016-09-01 |
The Johns Hopkins University |
Assay to diagnose and treat disorders of the alternative pathway of complement activation
|
|
ES2941640T3
(es)
|
2015-12-16 |
2023-05-24 |
Ra Pharmaceuticals Inc |
Moduladores de la actividad del complemento
|
|
MX2019006527A
(es)
|
2016-12-07 |
2019-08-01 |
Ra Pharmaceuticals Inc |
Moduladores de la actividad del complemento.
|
|
TWI826364B
(zh)
*
|
2017-04-03 |
2023-12-21 |
德商因夫萊亞斯有限公司 |
活性抑制劑於發炎性疾病之治療
|